• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Influence of pharmaceuticals on the development of obesity

    Bazhora Yana Igorivna, Lahoda Daria Oleksandrivna, Velychko Valentyna Ivanivna

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 4122-4126

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Ukraine has been at war for almost a year. This cannot but affect the mental health of the nation. Anxiety-depressive disorders (ADD) and other manifestations of psychological health disorders are increasingly registered among our citizens. At the same time, it is well known that certain groups of antipsychotic and antidepressant drugs have an impact on body weight (BW).
Material and methods:By design, the study involved 154 patients aged 18 to 55 years who were not diagnosed with obesity prior to the war. The study was conducted at the Department of Family Medicine and Polyclinic Therapy of the Odesa National Medical University. By design, patients were divided into three groups: 1 group - patients who received antipsychotics for the treatment of ADD; 2 group - patients who received antidepressants and group 3 - patients who did not receive pharmacological treatment of ADD.
Results: Study wasshowed that 53.90% of patients had depression of varying degrees, 46.10% of patients had anxiety. The general tendency of increasing the patient's BW corresponds to the global practice. Thus, the greatest increase in BW was observed in 38 patients (24.66%) who took antipsychotics, especially Clozapine, Olazapine or Haloperidol. These patients showed an increase, sometimes even up to 10-12 kg over 6 months of treatment.
Keywords:
  • PDF (201 K)
  • XML
(2023). Influence of pharmaceuticals on the development of obesity. European Journal of Molecular & Clinical Medicine, 10(1), 4122-4126.
Bazhora Yana Igorivna, Lahoda Daria Oleksandrivna, Velychko Valentyna Ivanivna. "Influence of pharmaceuticals on the development of obesity". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 4122-4126.
(2023). 'Influence of pharmaceuticals on the development of obesity', European Journal of Molecular & Clinical Medicine, 10(1), pp. 4122-4126.
Influence of pharmaceuticals on the development of obesity. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 4122-4126.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 13
  • PDF Download: 11
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus